LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

Search

Quidel Corp

Fechado

27.55 1.18

Visão Geral

Variação de preço das ações

24h

Atual

Mín

27.58

Máximo

28.09

Indicadores-chave

By Trading Economics

Funcionários

6,600

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+47.46% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

196M

1.6B

Abertura anterior

26.37

Fecho anterior

27.55

Quidel Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de ago. de 2025, 22:51 UTC

Ganhos

Wesfarmers Plans Special Payout to Shareholders as Annual Net Profit Rises 14%

27 de ago. de 2025, 23:57 UTC

Ganhos

Trip.com Group 1H Rev $4.01B

27 de ago. de 2025, 23:57 UTC

Ganhos

Trip.com Group 1H Adj EPS $1.84

27 de ago. de 2025, 23:57 UTC

Ganhos

Trip.com Group 1H EPS $1.82

27 de ago. de 2025, 23:50 UTC

Conversa de Mercado

Nikkei May Decline Amid Caution Over Tariff Impact, Chip Demand -- Market Talk

27 de ago. de 2025, 23:39 UTC

Ganhos

Correction to Nvidia Earnings Article -- WSJ

27 de ago. de 2025, 22:59 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 de ago. de 2025, 22:59 UTC

Conversa de Mercado

HP CEO Sees Strong Back-to-School Spending on PCs -- Market Talk

27 de ago. de 2025, 22:58 UTC

Ganhos

South32 Records Significant Items of $71 Million Tied to Worsley, Mozal

27 de ago. de 2025, 22:57 UTC

Ganhos

South32 FY Free Cash Flow $192 Million

27 de ago. de 2025, 22:56 UTC

Ganhos

South32 FY Total Capital Expenditure $1.35 Billion

27 de ago. de 2025, 22:56 UTC

Ganhos

South32 FY Capital Expenditure $963 Million, Excluding EAIs

27 de ago. de 2025, 22:55 UTC

Ganhos

South32 Net Cash $123 Million at June 30

27 de ago. de 2025, 22:54 UTC

Ganhos

South32: Focused on Maintaining Strong Operating Momentum

27 de ago. de 2025, 22:53 UTC

Ganhos

South32: $144 Million Remains to be Returned to Shareholders Under Program

27 de ago. de 2025, 22:53 UTC

Ganhos

South32 Extends Capital Management Program for 12 Months

27 de ago. de 2025, 22:52 UTC

Ganhos

South32 FY Underlying Ebitda $1.93 Billion, Up 7% On-Year

27 de ago. de 2025, 22:51 UTC

Ganhos

South32 FY Revenue $5.78 Billion, Up 17% On-Year

27 de ago. de 2025, 22:51 UTC

Ganhos

South32 FY Underlying Earnings $666 Million, Up 75% On-Year

27 de ago. de 2025, 22:50 UTC

Ganhos

South32 to Pay Final Dividend of 2.6 U.S. Cents/Share

27 de ago. de 2025, 22:50 UTC

Ganhos

South32 FY Net Profit $213 Million Vs $203 Million Loss Year Earlier

27 de ago. de 2025, 22:45 UTC

Ganhos

Sandfire Resources Expects FY26 Matsa Capital Expenditure of $148 Million

27 de ago. de 2025, 22:44 UTC

Ganhos

Sandfire Resources Expects FY26 Motheo Unit Cost of $44/Ton of Ore Processed

27 de ago. de 2025, 22:44 UTC

Ganhos

Sandfire Resources Expects FY26 Motheo Capital Expenditure of $82 Million

27 de ago. de 2025, 22:43 UTC

Ganhos

Sandfire Resources Expects FY26 Matsa Unit Cost of $86/Ton of Ore Processed

27 de ago. de 2025, 22:43 UTC

Ganhos

Nvidia Breaks Sales Record Despite Chinese Trade Hiccups -- 5th Update

27 de ago. de 2025, 22:42 UTC

Ganhos

Sandfire Resources Expects FY26 Motheo Copper Eq Output to Rise 3% to 61,000 Tons

27 de ago. de 2025, 22:42 UTC

Ganhos

Sandfire Resources Expects FY26 Matsa Copper Eq Output to Rise 2% to 96,000 Tons

27 de ago. de 2025, 22:40 UTC

Ganhos

Sandfire Resources Net Debt $123 Million at June 30

27 de ago. de 2025, 22:40 UTC

Ganhos

Sandfire Resources FY Underlying Ebitda $527.7 Million

Comparação entre Pares

Variação de preço

Quidel Corp Previsão

Preço-alvo

By TipRanks

47.46% parte superior

Previsão para 12 meses

Média 41.17 USD  47.46%

Máximo 60 USD

Mínimo 26 USD

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Quidel Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

8 ratings

4

Comprar

3

Manter

1

Vender

Informação Financeira

$

Sobre Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.